Chapter of Gastroenterologists professional guidance for management of patients with liver disease in Singapore during the COVID-19 pandemic.
- Author:
Jason Pik Eu CHANG
1
;
Yu Jun WONG
2
;
Wei Lyn YANG
3
;
Kieron Boon Leng LIM
4
;
Poh Seng TAN
5
;
Gim Hin HO
1
;
Benjamin Cherng Hann YIP
1
;
James Weiquan LI
1
;
Chern Hao CHONG
1
;
David Eng Hui ONG
1
;
Tju Siang CHUA
1
;
Charles Kien Fong VU
1
;
Kok Ann GWEE
1
;
Tiing Leong ANG
1
;
Chee Kiat TAN
6
Author Information
- Publication Type:Practice Guideline
- Keywords: COVID-19; SARS-CoV-2; hepatology
- MeSH: COVID-19/epidemiology*; Carcinoma, Hepatocellular/therapy*; Chronic Disease; Hepatitis B, Chronic/therapy*; Hepatitis C, Chronic/therapy*; Humans; Liver Cirrhosis/therapy*; Liver Diseases/therapy*; Liver Neoplasms/therapy*; Liver Transplantation; Singapore/epidemiology*
- From:Singapore medical journal 2020;61(12):619-623
- CountrySingapore
- Language:English
- Abstract: In this paper, we aim to provide professional guidance to clinicians who are managing patients with chronic liver disease during the current coronavirus disease 2019 (COVID-19) pandemic in Singapore. We reviewed and summarised the available relevant published data on liver disease in COVID-19 and the advisory statements that were issued by major professional bodies, such as the American Association for the Study of Liver Diseases and European Association for the Study of the Liver, contextualising the recommendations to our local situation.
